Evidence map›Paper›PMID 30045874›Full record

ArticleThe Biochemical journal2018

A role for trypanosomatid aldo-keto reductases in methylglyoxal, prostaglandin and isoprostane metabolism.

Adam J Roberts, Joanne Dunne, Paul Scullion, Suzanne Norval, Alan H Fairlamb

Abstract read
In one paragraph

Article in The Biochemical journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Fatty Acid Composition and Metabolism inInternational journal of molecular sciences · 2023
    Review
  5. New Insights into the Role of thePathogens (Basel, Switzerland) · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Leishmania braziliensis prostaglandin FParasites & vectors · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Adam J RobertsDivision of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.
Joanne DunneDivision of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.
Paul ScullionDivision of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.
Suzanne NorvalDivision of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.
Alan H FairlambDivision of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K. a.h.fairlamb@dundee.ac.uk.ORCID 0000-0001-5134-0329

Funding

Wellcome Trust 079838Wellcome Trust 203134/Z/16/ZWellcome Trust OPP1066891
6 · The paper itself

Abstract

Trypanosomatid parasites are the infectious agents causing Chagas disease, visceral and cutaneous leishmaniasis and human African trypanosomiasis. Recent work of others has implicated an aldo-keto reductase (AKR) in the susceptibility and resistance of

Indexed as

Aldo-Keto ReductasesDinoprostIsoprostanesLeishmania donovaniProtozoan ProteinsPyruvaldehydeTrypanosoma brucei bruceiTrypanosoma cruzi8-epi-prostaglandin F2alphaAldo-Keto ReductasesDinoprostIsoprostanesProtozoan ProteinsPyruvaldehydealdo-keto reductasesdrug metabolismisoprostanelipid mediatorsmethylglyoxaltrypanosomes

Identifiers

PMID30045874
PMCPMC6117947

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.